Related Experiment Video
Updated: Feb 10, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
The Role of scaRNAs in Adjusting Alternative mRNA Splicing in Heart Development
Chloe Nagasawa1, Allison Ogren2, Nataliya Kibiryeva3
1College of Biosciences, Kansas City University, Kansas City, MO 64106, USA. cnagasawa94@kcumb.edu.
Insights
Small cajal body-associated RNAs (scaRNAs) are significantly reduced in Tetralogy of Fallot (TOF) hearts. This reduction impacts mRNA splicing, leading to congenital heart defects in infants and zebrafish models.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- Congenital heart disease (CHD) is a major cause of infant mortality, with unknown etiology in ~70% of cases.
- Tetralogy of Fallot (TOF), a conotruncal defect, necessitates early surgical intervention.
- Noncoding RNAs play crucial roles in cellular function and development.
Purpose of the Study:
- To investigate the role of noncoding RNAs, specifically small cajal body-associated RNAs (scaRNAs), in the pathogenesis of Tetralogy of Fallot (TOF).
- To explore the link between scaRNA dysregulation, mRNA splicing, and heart development defects.
Main Methods:
- Analysis of noncoding transcriptome in myocardial tissue from infants with TOF.
- Quantification of specific small cajal body-associated RNAs (scaRNAs) in right ventricle tissue.
- Utilizing a zebrafish model to assess the impact of altered scaRNA expression on heart development and mRNA processing.
Main Results:
- Significant variations in noncoding RNA expression were observed in TOF hearts.
- A notable reduction in 12 specific scaRNAs was identified in the right ventricle of TOF patients.
- Dysregulated mRNA splicing critical for heart development was documented in TOF infant heart tissue.
- Altering scaRNA expression in zebrafish resulted in faulty mRNA processing and embryonic heart defects.
Conclusions:
- Small cajal body-associated RNAs (scaRNAs) are significantly reduced in congenital heart defects like TOF.
- scaRNA deficiency disrupts mRNA splicing fidelity, contributing to faulty heart development.
- scaRNAs represent a potential regulatory mechanism in heart development and a target for future research.
Abstract:
Congenital heart disease (CHD) is a leading cause of death in children <1 year of age. Despite intense effort in the last 10 years, most CHDs (~70%) still have an unknown etiology. Conotruncal based defects, such as Tetralogy of Fallot (TOF), a common complex of devastating heart defects, typically requires surgical intervention in the first year of life. We reported that the noncoding transcriptome in myocardial tissue from children with TOF is characterized by significant variation in levels of expression of noncoding RNAs, and more specifically, a significant reduction in 12 small cajal body-associated RNAs (scaRNAs) in the right ventricle. scaRNAs are essential for the biochemical modification and maturation of small nuclear RNAs (spliceosomal RNAs), which in turn are critical components of the spliceosome. This is particularly important because we also documented that splicing of mRNAs that are critical for heart development was dysregulated in the heart tissue of infants with TOF. Furthermore, we went on to show, using the zebrafish model, that altering the expression of these same scaRNAs led to faulty mRNA processing and heart defects in the developing embryo. This review will examine how scaRNAs may influence spliceosome fidelity in exon retention during heart development and thus contribute to regulation of heart development.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Pre-mRNA Processing: RNA Splicing
RNA Splicing
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

